WHO nod for Covaxin likely this month

New Delhi: The World Health Organization’s approval for the indigenous Covid-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to come this month, official sources said Monday.

The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China’s Sinopharm and Oxford-AstraZeneca for emergency use.

Covaxin is one of the six vaccines that have received emergency use authorisation from India’s drug regulator and is being used in the nationwide inoculation programme, alongwith Covishield and Sputnik V.

“The WHO approval for Covaxin is likely this month,” an official source said. PTI

  • Related Posts

    CDSCO constitutes consultancy committee for advice on suo motu disclosure

    The Central Drugs Standard Control Organisation (CDSCO) has constituted the consultancy committee of key stakeholders for advice on suo motu disclosure under the Right to Information Act, 2005, with six…

    Telangana DCA busts illegal API stock, seizes drugs worth Rs 34L

    Hyderabad: The Telangana Drugs Control Administration (DCA) conducted raids at multiple pharmacies in Medchal-Malkajgiri and Nalgonda districts and seized Active Pharmaceutical Ingredients (APIs) worth Rs 34 lakh and medicines worth…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    CDSCO constitutes consultancy committee for advice on suo motu disclosure

    CDSCO constitutes consultancy committee for advice on suo motu disclosure

    Telangana DCA busts illegal API stock, seizes drugs worth Rs 34L

    Telangana DCA busts illegal API stock, seizes drugs worth Rs 34L

    Zenré Wellness, a New Genre of Mental Care, unveils in Delhi

    Zenré Wellness, a New Genre of Mental Care, unveils in Delhi

    Raids On Many Hospitals Across Kerala In Organ Trafficking Probe

    Raids On Many Hospitals Across Kerala In Organ Trafficking Probe

    Over-the-counter sale of cough syrup barred

    Over-the-counter sale of cough syrup barred

    FDA seals Bhiwandi-based cosmetic factory for misleading claims, fake address

    FDA seals Bhiwandi-based cosmetic factory for misleading claims, fake address